Latest Financial Planning News

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.

Genetic Technologies Limited has signed binding term sheets to acquire Ellerfield Wealth and Walker Capital, marking a strategic shift into wealth management backed by a $7.8 million valuation and pending ASX approvals.

The Australian Government has delayed the rollout of the new Aged Care Act 2024, postponing key funding reforms from July to November 2025. Regis Healthcare acknowledges the delay and promises ongoing updates.

The Australian Wealth Advisors Group has deepened its Equity Partnership Scheme with strategic stakes in Oneledger and B2B Invest, setting up royalty revenue streams that align with its expansion in financial services.

Australian Wealth Advisors Group (AWAG) has completed strategic investments in Oneledger Group and B2B Invest, positioning itself for a net profit before tax exceeding $900k in 2026.

Mineral Commodities Ltd reveals ongoing delays in completing the sale of its Skaland Graphite Project due to funding issues faced by the buyer, Norge Mineraler. Despite partial payments and new guarantees, the final USD 9.62 million payment remains outstanding.

Yowie Group intensifies efforts to reclaim a substantial loan from Keybridge Capital, issuing a statutory demand and launching a share placement to shore up finances amid tariff challenges.

360 Capital Group has extended the closing date for its Off-Market Equal Access Buy-Back by one week to 21 May 2025, offering eligible securityholders additional time to participate. This adjustment also shifts key dates for payment and cancellation of securities.

QPM Energy reports a substantial 61% upgrade in Moranbah Gas Project reserves to 435PJ, successfully integrates Moranbah Power Station operations, and begins overhaul of Townsville Power Station, navigating weather disruptions and contract renewals.

Health and Plant Protein Group Limited has dramatically reduced its half-year net loss to $43,000 following the divestment of its macadamia division, though uncertainty lingers over a significant IRS receivable in the US.

Fiducian Group has delivered a robust FY2025 half-year performance, marked by strong net inflows and a 23% rise in funds under administration, underpinning solid revenue growth and a confident dividend outlook.

Atlas Arteria reveals it will face a significant temporary supplemental tax under France’s new 2025 Finance Law, impacting its APRR Group operations with payments due late next year.